CHA₂DS₂-VASc — Stroke Risk in Atrial Fibrillation

ESC 2020 validated score to estimate the annual stroke risk in patients with atrial fibrillation.

Privacy first Source: ESC guidelines Runs in your browser
Information tool — it does not replace a doctor. The author is not a doctor. The result is a statistical estimate based on public guidelines: any decision on diagnosis or treatment is for your doctor.

Calculate your score

0 / 9

Check the risk factors that apply to your situation. Each check adds points to the total score.

What is Atrial Fibrillation?

The heart normally beats rhythmically, like a precise clock. In Atrial Fibrillation (AF), the heart loses its rhythm and begins to beat chaotically.

This chaotic rhythm causes blood to pool in the heart chambers, potentially forming clots. If a clot breaks loose and travels to the brain, it blocks an artery, causing a stroke.

How does CHA₂DS₂-VASc work?

It is a risk stratification tool used by cardiologists worldwide. Each factor adds points; the higher the score, the higher the risk.

Letter Risk factor Points
CHeart failure1
HHigh blood pressure1
A₂Age ≥ 75 years2
DDiabetes1
S₂Stroke/TIA2
VVascular disease1
AAge 65-741
ScFemale sex1
Maximum score9

What does the score mean?

Score Risk/year Men Women
00%No treatmentLow risk
11,3%Consider anticoagulantNo treatment
22,2%RecommendedConsider anticoagulant
≥3>3,2%RecommendedRecommended

Note: in women, the point for sex does not count on its own.

Everything you want to know.

What is atrial fibrillation?

Atrial fibrillation is a common heart rhythm disorder where the upper chambers (atria) beat irregularly.

What is CHA₂DS₂-VASc?

It is a clinical score developed to help physicians decide whether an anticoagulation therapy is needed.

Does a high score mean I will definitely have a stroke?

No. The score indicates probability, not certainty. It guides therapeutic decisions.

What are anticoagulants?

Drugs that make blood less "sticky", reducing the risk of clot formation.

Can I use it without atrial fibrillation?

No. It is validated only for people with atrial fibrillation.

How often should the score be reassessed?

At least once a year, or whenever your clinical situation changes.

Hindricks G et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
Lip GYH et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation (CHA₂DS₂-VASc). Chest. 2010;137(2):263–272.
Van Gelder IC et al. 2024 ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2024;45(36):3314–3414.
Friberg L et al. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation. Eur Heart J. 2012;33(12):1500–1510.